Article
Genomic instability and poor prognosis associated with abnormal TP53 in breast carcinomas. Molecular and immunohistochemical analysis.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica - 1 Feb 1997
Valgardsdottir R, Tryggvadottir L, Steinarsdottir M, Olafsdottir K, Jonasdottir S, Jonasson J G, Ogmundsdottir H M, Eyfjörd J E
Abstract excerpt
Alterations of the TP53 gene were analyzed in samples from 87 primary breast cancer patients, using molecular and immunohistochemical approaches. Mutations were detected in 17% of the samples, using polymerase chain reaction (PCR) and constant denaturant gel electrophoresis (CDGE) on exons 5-8 of...
Topics
- Adult
- Aged
- Aged, 80 and over
- Breast Neoplasms
- Carcinoma
- Genes, p53
- Humans
- Immunohistochemistry
- Middle Aged
- Mutation
- Prognosis
- Receptor, ErbB-2
- Tumor Suppressor Protein p53